| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/09/2006 | US7041280 Aryl boronate functionalized polymers for treating obesity |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2346662C Compositions containing diphosphonic acids |
| 05/09/2006 | CA2322341C Highly resistant granular starch |
| 05/09/2006 | CA2141652C Fluorinated vitamin d3 derivative |
| 05/04/2006 | WO2006047248A1 Combination of dpp-iv inhibitor, ppar antidiabetic and metformin |
| 05/04/2006 | WO2006046779A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 05/04/2006 | WO2006046774A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 05/04/2006 | WO2006046738A1 Process for producing indigestible dextrin containing isomerized sugar |
| 05/04/2006 | WO2006046626A1 Water-soluble elastins, process for producing the same, and food and medicine containing the same |
| 05/04/2006 | WO2006046623A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 05/04/2006 | WO2006046603A1 Islet transplantation auxiliary |
| 05/04/2006 | WO2006046557A1 Abnormal protein removing composition |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | WO2006046402A1 Triglyceride metabolism controlling agent and containing the same, food, drink, food additive and pharmaceutical |
| 05/04/2006 | WO2006045865A1 Pharmaceutical formulation comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 05/04/2006 | WO2006045799A2 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| 05/04/2006 | WO2006045478A1 New indole or benzimidazole derivatives |
| 05/04/2006 | WO2006023630A3 The use of n-aryl diazaspiracyclic compounds in the treatment of addiction |
| 05/04/2006 | WO2005123718A3 Benzimidazolone carboxylic acid derivatives |
| 05/04/2006 | WO2005113606A3 Fgf-21 fusion proteins |
| 05/04/2006 | WO2005106492A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
| 05/04/2006 | WO2005063169A3 Medical lipolysis of fat accumulations |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | US20060094902 Amino acid analogues |
| 05/04/2006 | US20060094884 Benzothiazepine and benzothiepine derivatives |
| 05/04/2006 | US20060094768 Thiophene derivative ppar modulators |
| 05/04/2006 | US20060094740 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 05/04/2006 | US20060094733 Purine derivatives as liver x receptor agonists |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094722 Combination drug |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094711 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094667 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 05/04/2006 | US20060094013 Salt-inducible kinases 2 and use thereof |
| 05/04/2006 | US20060093680 Coated particles and pharmaceutical dosage forms |
| 05/04/2006 | US20060093651 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | CA2730374A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 05/04/2006 | CA2585642A1 Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 05/04/2006 | CA2585175A1 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| 05/04/2006 | CA2585030A1 New indole or benzimidazole derivatives |
| 05/04/2006 | CA2583756A1 Pharmaceutical composition comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 05/04/2006 | CA2581298A1 Combination of dpp-iv inhibitor, ppar antidiabetic and metformin |
| 05/04/2006 | CA2580919A1 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 05/03/2006 | EP1652913A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/03/2006 | EP1652856A1 Stress proteins-derived peptides and method of use thereof |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1651644A1 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same |
| 05/03/2006 | EP1651636A1 Substituted heterocyclic diarylamine analogues |
| 05/03/2006 | EP1651623A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651616A2 Pyridazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651615A1 Pyridazinyl- piperazines and their use as histamine h3 receptor ligands |
| 05/03/2006 | EP1651605A2 Pyridyl derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651342A2 Combinatorial synthesis on support |
| 05/03/2006 | EP1651251A2 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP1651220A1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/03/2006 | EP1651213A1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 05/03/2006 | EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 05/03/2006 | EP1553969B1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1465870B1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 05/03/2006 | EP1444224B1 3-substituted oxindole beta-3 agonists |
| 05/03/2006 | EP1355638B1 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 05/03/2006 | EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1240822B1 Diabetes onset model mammal |
| 05/03/2006 | EP1225809B1 Methods for stabilizing liquid nutritional products and products so stabilized |
| 05/03/2006 | EP1209988B1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | CN1768073A Oligosaccharide derivative |
| 05/03/2006 | CN1768071A Lipid-regulating agent and use thereof |
| 05/03/2006 | CN1768058A Imidazopyridine derivatives as melanocortin receptor agonists. |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1768035A Anti-obesity agent |
| 05/03/2006 | CN1768034A Nover diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 05/03/2006 | CN1765931A GLP-1 fusion protein and its preparation method and medicinal uses |
| 05/03/2006 | CN1765893A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/03/2006 | CN1765890A Modulators of dopamine neurotransmission |
| 05/03/2006 | CN1765886A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/03/2006 | CN1765407A Blood fat decreasing pill |
| 05/03/2006 | CN1765381A Conditioning qi-invigorating weight-reducing extract |
| 05/03/2006 | CN1765376A Application of H. seniavinii in preparation of weight-reducing food |
| 05/03/2006 | CN1765375A Application of H. seniavinii in preparation of food for resisting depression or/and promoting memory for learning |
| 05/03/2006 | CN1765362A Composition containing amlodipine and angiotensin II receptor inhibitor |
| 05/03/2006 | CN1254478C Derivatives of monosaccharides as well adhesion inhibitors |
| 05/03/2006 | CN1254469C Arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 05/03/2006 | CN1254268C Serier compound Chinese herbal medicine pure natural high-calcium preparation |
| 05/03/2006 | CN1254249C Animal used injection with calcium, phosphorus, magnesium or just calcium and phosphorus and preparing process thereof |
| 05/03/2006 | CN1254240C Silibinin meglumine salt oral disintegration tablet and its preparing method |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |